HBeAg阴性的慢性乙型肝炎113例三年随访观察

R512.6+2; 了解HBeAg阴性慢性乙型肝炎(e-CHB)的预后和转归.对113例HBeAg/HBeAb血清转换后的e-CHB患者随访三年,观察其发展变化和预后转归.e-CHB患者的复发率低于e+CHB,干扰素治疗后的e-CHB复发率高而肝硬化的发生率低.干扰素治疗e+CHB有较高的远期疗效和抗肝纤维化作用....

Full description

Saved in:
Bibliographic Details
Published in临床肝胆病杂志 Vol. 20; no. 2; p. 117
Main Authors 何炳福, 周建康, 沈华江
Format Journal Article
LanguageChinese
Published 绍兴市中医院,浙江,绍兴,312000%绍兴市第六人民医院,浙江,绍兴,312000 2004
Subjects
Online AccessGet full text
ISSN1001-5256
DOI10.3969/j.issn.1001-5256.2004.02.026

Cover

Abstract R512.6+2; 了解HBeAg阴性慢性乙型肝炎(e-CHB)的预后和转归.对113例HBeAg/HBeAb血清转换后的e-CHB患者随访三年,观察其发展变化和预后转归.e-CHB患者的复发率低于e+CHB,干扰素治疗后的e-CHB复发率高而肝硬化的发生率低.干扰素治疗e+CHB有较高的远期疗效和抗肝纤维化作用.
AbstractList R512.6+2; 了解HBeAg阴性慢性乙型肝炎(e-CHB)的预后和转归.对113例HBeAg/HBeAb血清转换后的e-CHB患者随访三年,观察其发展变化和预后转归.e-CHB患者的复发率低于e+CHB,干扰素治疗后的e-CHB复发率高而肝硬化的发生率低.干扰素治疗e+CHB有较高的远期疗效和抗肝纤维化作用.
Author 沈华江
周建康
何炳福
AuthorAffiliation 绍兴市中医院,浙江,绍兴,312000%绍兴市第六人民医院,浙江,绍兴,312000
AuthorAffiliation_xml – name: 绍兴市中医院,浙江,绍兴,312000%绍兴市第六人民医院,浙江,绍兴,312000
Author_xml – sequence: 1
  fullname: 何炳福
– sequence: 2
  fullname: 周建康
– sequence: 3
  fullname: 沈华江
BookMark eNo9jzFLAzEcxTNUsNZ-CweXO_NPLrlkrEWtUHDpXnK55GgpKXiI0EkOHaSgqxZUcOmmSwe76Je5a6_fwhNFePAeb3iP3w6qubEzCO0B9qnk8mDoD9LU-YAxeIww7hOMAx-TSryG6v_9Nmqm6SDCDCiXAeN1JDqHppVsHharq_l6dr26ea1Cvnwsnqdl9rTO7gBo_jnNP26L5WIzuy_fvsp5Vry_7KItq0apaf55A_WOj3rtjtc9Ozltt7qeZpJ7nDJNQBnAQoCSoVQiZIwSKWMtLOeh0kCiOKAxgDHChpQpay2NIi1CIJI20P7v7KVyVrmkPxxfnLvqsD_SSRxNJj-kmFSc9Btlcly1
ClassificationCodes R512.6+2
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1001-5256.2004.02.026
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 117
ExternalDocumentID lcgdbzz200402026
GroupedDBID -05
2B.
4A8
5XA
5XF
92F
92I
93N
ABDBF
ABJNI
ACGFS
ACUHS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CW9
EAD
EAP
EOJEC
ESX
IPNFZ
OBODZ
OK1
PSX
RIG
RNS
TCJ
TGQ
U1G
U5O
ID FETCH-LOGICAL-c596-635c21ae10881a979a87553299dc8f667ac12bd43d11ee8f735afff3bbc871293
ISSN 1001-5256
IngestDate Thu May 29 03:59:48 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords 预后
慢性乙型肝炎
HBeAg
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c596-635c21ae10881a979a87553299dc8f667ac12bd43d11ee8f735afff3bbc871293
PageCount 1
ParticipantIDs wanfang_journals_lcgdbzz200402026
PublicationCentury 2000
PublicationDate 2004
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 2004
PublicationDecade 2000
PublicationTitle 临床肝胆病杂志
PublicationTitle_FL CHINESE JOURNAL OF CLINICAL HEPATOLOGY
PublicationYear 2004
Publisher 绍兴市中医院,浙江,绍兴,312000%绍兴市第六人民医院,浙江,绍兴,312000
Publisher_xml – name: 绍兴市中医院,浙江,绍兴,312000%绍兴市第六人民医院,浙江,绍兴,312000
SSID ssib051369456
ssj0041983
ssib001103858
ssib053243598
ssib002264326
ssib038074677
Score 1.6
Snippet R512.6+2; 了解HBeAg阴性慢性乙型肝炎(e-CHB)的预后和转归.对113例HBeAg/HBeAb血清转换后的e-CHB患者随访三年,观察其发展变化和预后转归.e-CHB患者的复发率低于e+CHB,干扰素治疗后的e-CHB复发率高而肝硬化的发生率低.干扰素治疗e+CHB有较高的远期疗效和抗肝纤维化作用.
SourceID wanfang
SourceType Aggregation Database
StartPage 117
Title HBeAg阴性的慢性乙型肝炎113例三年随访观察
URI https://d.wanfangdata.com.cn/periodical/lcgdbzz200402026
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1NaxNBdGgrFC_iJ35ToXPcmpmdmZ057qYbglBPEXoru5vdepAINb3kIBL0IAW9akEFL73ppQd70ZP_JGnTf-F7M5tkG6VUEcIymXmf-5h9b4f33hKynHABcXIuPSVy7gmZFl7SNr6X6yJnOWPtWmGzLR6q5iPxYF2uz83_rGQtbXfTlaz3x7qSf7EqzIFdsUr2Lyw7IQoTMAb7whUsDNcz2bgZ5eEmjQ01mkaCxgrzFsKAxgE1IdVuRtKQV5YEjQDe0FhSE1Md0VhTzalZRSwY6Jgx34K5VRgAgIUHRORiLPEGIoYxjdzA4gJM2KDmRKpgSQERgQIghhWOMPCpVlbgAEUFOWHekQLKZuIlLZlVamQpZuTjIAS1GlMQUInRUFvkCJk5llGFiqIR6GhBNDCK7Qwbyzw-_pgefCIXoAWwiCHHelgNnGahW6ojWGxvLdxvXreEpb3TJQc7-Rs1XvcZFjJRLk_lBcrW8eeWkKmwuoWWfg01_x9iVJwUpsFJ7hqyj70Yr1V2K6-4JOZqY8vopvw36zh9o4x1nMhgZcLAnp_YnrZ8pl-5jYCeZJvttNdDIHjr4GqenONBwDCzdu15PI3KWe1EyySs3a68NeAnD0Slq6JkvjJi2uJJQsyPfSbHAZZgRru6mVLKRbJcqnD_NAVsWV6nSDqblQiydZFcKF_9lkK3jy-Rud7jy2RxrUxuuUK03c7H7_YPX-wd7b48fPUZBoOD98OPO6P-h6P-G9iYg-87g2-vhwf7x7tvR19-jPb6w6-frpJWI27Vm175YRMvk0Z5EONnnCU5Aw_PEhOYRAcStDSmnelCqSDJGE_bwm8zlsNDM_BlUhSFn6aZDjA-v0YWOk87-XWylCmdZwmTiV9ooRNfZwor3Y2o5djZSd0g90qdN8rn1rONWavdPAPMLXLepazh2eNtstDd2s7vQDTeTe9aW_8C9Dic6g
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HBeAg%E9%98%B4%E6%80%A7%E7%9A%84%E6%85%A2%E6%80%A7%E4%B9%99%E5%9E%8B%E8%82%9D%E7%82%8E113%E4%BE%8B%E4%B8%89%E5%B9%B4%E9%9A%8F%E8%AE%BF%E8%A7%82%E5%AF%9F&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E4%BD%95%E7%82%B3%E7%A6%8F&rft.au=%E5%91%A8%E5%BB%BA%E5%BA%B7&rft.au=%E6%B2%88%E5%8D%8E%E6%B1%9F&rft.date=2004&rft.pub=%E7%BB%8D%E5%85%B4%E5%B8%82%E4%B8%AD%E5%8C%BB%E9%99%A2%2C%E6%B5%99%E6%B1%9F%2C%E7%BB%8D%E5%85%B4%2C312000%25%E7%BB%8D%E5%85%B4%E5%B8%82%E7%AC%AC%E5%85%AD%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%2C%E6%B5%99%E6%B1%9F%2C%E7%BB%8D%E5%85%B4%2C312000&rft.issn=1001-5256&rft.volume=20&rft.issue=2&rft.spage=117&rft.epage=117&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2004.02.026&rft.externalDocID=lcgdbzz200402026
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg